SUZANE VILLARINI: Open Payments
NPI 1174699862 · WEST CHESTER, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$704 in 35 payments from 21 companies in 2025. Trend: 2023 $479 · 2024 $826 · 2025 $704
Food & beverage: $704
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 4 | $78 |
| GlaxoSmithKline, LLC. | 3 | $69 |
| Astellas Pharma US Inc | 3 | $66 |
| AstraZeneca Pharmaceuticals LP | 3 | $50 |
| Inspire Medical Systems, Inc. | 2 | $42 |
| ABBVIE INC. | 2 | $42 |
| Lilly USA, LLC | 2 | $42 |
| Lundbeck LLC | 2 | $40 |
| CSL Behring | 1 | $39 |
| Amgen Inc. | 2 | $32 |
Products named: Veozah, REXULTI, NURTEC ODT, TRELEGY ELLIPTA, INSPIRE, QULIPTA, MOUNJARO, Andembry.
Industry payments across PA — which companies pay providers there.
